Spain |
|
|
|
|
|
|
Perceived usefulness of ICTS in clinical practice |
0.200 |
0.445 |
0.202 |
1 |
0.653 |
1.222 |
Ease-of-use of ICTS in clinical practice |
0.667 |
0.364 |
3.354 |
1 |
0.067 |
1.948 |
Optimism |
−0.498 |
0.437 |
1.302 |
1 |
0.254 |
0.607 |
Propensity to innovate |
0.724 |
0.373 |
3.769 |
1 |
0.052 |
2.062 |
Level of ICT use |
2.661 |
1.077 |
6.103 |
1 |
0.013 |
14.316 |
Constant |
0.724 |
0.373 |
3.769 |
1 |
0.052 |
2.062 |
Chi-square, 24.859; significant, 0.000 |
|
|
|
|
|
|
Hosmer-Lemeshow test, 19.273; significant, 0.018 |
|
|
|
|
|
|
Nagelkerke R Square, 0.275 |
|
|
|
|
|
|
Colombia |
|
|
|
|
|
|
Perceived usefulness of ICTS in clinical practice |
−0.192 |
0.253 |
0.575 |
1 |
0.448 |
0.826 |
Ease-of-use of ICTS in clinical practice |
0.108 |
0.182 |
0.347 |
1 |
0.556 |
1.113 |
Optimism |
0.485 |
0.269 |
3.254 |
1 |
0.071 |
1.624 |
Propensity to innovate |
0.361 |
0.232 |
2.423 |
1 |
0.120 |
1.435 |
Level of ICT use |
1.212 |
0.511 |
5.626 |
1 |
0.018 |
3.360 |
Constant |
−2.878 |
0.951 |
9.163 |
1 |
0.002 |
0.056 |
Chi-square, 14.489; significant, 0.013 |
|
|
|
|
|
|
Hosmer-Lemeshow test, 14.564; significant, 0.045 |
|
|
|
|
|
|
Nagelkerke R Square, 0.161 |
|
|
|
|
|
|
Bolivia |
|
|
|
|
|
|
Perceived usefulness of ICTS in clinical practice |
0.131 |
0.141 |
0.866 |
1 |
0.352 |
1.140 |
Ease-of-use of ICTS in clinical practice |
0.321 |
0.256 |
1.571 |
1 |
0.210 |
1.379 |
Optimism |
0.484 |
0.150 |
10.371 |
1 |
0.001 |
1.622 |
Propensity to innovate |
0.033 |
0.189 |
0.031 |
1 |
0.861 |
1.034 |
Level of ICT use |
2.040 |
1.049 |
3.780 |
1 |
0.052 |
7.689 |
Constant |
-2.224 |
1.375 |
2.618 |
1 |
0.106 |
0.108 |
Chi-square, 20.704; significant, 0.000 |
|
|
|
|
|
|
Hosmer-Lemeshow test, 14.705; significant, 0.072 |
|
|
|
|
|
Nagelkerke R Square, 0.197 |
|
|
|
|
|